InvestorsObserver
×
News Home

Will Tenax Therapeutics Inc (TENX) Stay at the Bottom of the Healthcare Sector?

Thursday, March 09, 2023 12:49 PM | InvestorsObserver Analysts

Mentioned in this article

Will Tenax Therapeutics Inc (TENX) Stay at the Bottom of the Healthcare Sector?

Tenax Therapeutics Inc (TENX) is near the bottom in its sector according to InvestorsObserver. TENX gets an overall rating of 0. That means it scores higher than 0% of stocks. Tenax Therapeutics Inc gets a 23 rank in the Healthcare sector. Healthcare is number 3 out of 11 sectors.

Overall Score - 0
TENX has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on TENX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 0 would rank higher than 0 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Tenax Therapeutics Inc Stock Today?

Tenax Therapeutics Inc (TENX) stock is trading at $0.51 as of 12:49 PM on Thursday, Mar 9, a drop of -$0.06, or -10.48% from the previous closing price of $0.57. The stock has traded between $0.48 and $0.55 so far today. Volume today is more active than usual. So far 5,983,925 shares have traded compared to average volume of 3,247,581 shares. Click Here to get the full Stock Report for Tenax Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App